Targeting mechanosensitive protein could treat pulmonary fibrosis, study suggests
A safer MRI contrast agent for high-resolution 3D microvascular imaging
10 March 2021Researchers develop guidelines for reporting polygenic risk scores
10 March 2021Targeting mechanosensitive protein could treat pulmonary fibrosis, study suggests
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF). The study, which will be published March 10 in the Journal of Experimental Medicine (JEM), suggests that targeting a protein called MDM4 could prevent respiratory failure by initiating a genetic program that removes scar tissue from the lungs.
